BLT Stock News 12.01 05/15/2014 16:37:51 Blount International

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Blount International (BLT) 12.01 $BLT

Altra Industrial's New Share Buyback Plan - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 2 hrs 17 mins ago
For the first time, Altra Industrial (AIMC) has announced a share repurchase program. The company will buy back up to $50 million worth of shares through Dec 2016.

The Dixie Group (DXYN) in Focus: Stock Tumbles 8.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 15, 7:57AM CDT
The Dixie Group, Inc. (DXYN) saw a big move last session,continuing the recent downtrend for DXYN, as the stock is now down more than 24% in the past one-month time frame.

Deere Shares Dip as Earnings Lag Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed May 14, 10:08AM CDT
Shares of Deere & Company (DE) dipped 1.78% on reporting a decline in earnings.

NYSE stocks posting largest volume increases
AP - Tue May 13, 5:18PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:

Manitex Earnings Lag Estimates, Shares Fall - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue May 13, 9:10AM CDT
Manitex's (MNTX) first-quarter earnings lagged the Zacks Consensus Estimate.

Blount International Has Returned 12.4% Since SmarTrend Recommendation (BLT)
Comtex SmarTrend(R) - Fri May 09, 9:24AM CDT
SmarTrend identified a Downtrend for Blount International (NYSE:BLT) on January 27th, 2014 at $12.78. In approximately 3 months, Blount International has returned 12.44% as of today's recent price of $11.19.

Why Blount International (BLT) Stock Is Higher Today
at The Street - Fri May 09, 8:58AM CDT
Blount International (BLT) stock is up after the company reported an increase in net income for the 2014 first quarter.

Blount Announces First Quarter 2014 Results
GlobeNewswire - Fri May 09, 7:00AM CDT
-- First quarter 2014 sales of $232.0 million, flat compared to 2013

Blount Schedules Conference Call to Discuss First Quarter 2014 Results
GlobeNewswire - Wed May 07, 2:40PM CDT
Blount International, Inc. (NYSE:BLT) ("Blount" or the "Company" will release first quarter 2014 financial results on Friday, May 9, 2014 at approximately 8:00 a.m. EDT (5:00 a.m. PDT). Blount will hold a conference call to discuss its results on Friday, May 9, 2014 at 1:00 p.m. EDT (10:00 a.m. PDT). To participate, please call 1-800-860-2442 domestically (+1-412-858-4600 internationally) and enter the conference number 10045853.

13.8% Return Seen to Date on SmarTrend Blount International Call (BLT)
Comtex SmarTrend(R) - Thu May 01, 5:01PM CDT
SmarTrend identified a Downtrend for Blount International (NYSE:BLT) on January 27th, 2014 at $12.78. In approximately 3 months, Blount International has returned 13.77% as of today's recent price of $11.02.

Blount International Announces New Board Member
GlobeNewswire - Mon Apr 28, 3:30PM CDT
Blount International, Inc. (NYSE:BLT) ("Blount" or "Company" announced today that its Board of Directors (the "Board" has elected Daniel J. Obringer as a Director, effective April 25, 2014. Mr. Obringer's appointment fills the vacancy created by the departure of Mr. Thomas J. Fruechtel, who resigned his position as a member of the Board on April 24, 2014.

8.2% Return Seen to Date on SmarTrend Blount International Call (BLT)
Comtex SmarTrend(R) - Thu Apr 24, 11:22AM CDT
SmarTrend identified a Downtrend for Blount International (NYSE:BLT) on January 27th, 2014 at $12.78. In approximately 3 months, Blount International has returned 8.22% as of today's recent price of $11.73.

Blount Files Annual Report on Form 10-K and Reports 2013 Results
GlobeNewswire - Wed Apr 23, 7:01AM CDT
-- Full year 2013 sales were $901 million and Adjusted EBITDA was $123 million

Benitec Biopharma Completes AUD $31.5 million Private Placement
PR Newswire - Tue Apr 15, 7:30AM CDT
Benitec Biopharma Limited (ASX: BLT), today announced it has completed its previously announced private placement of up to approximately 29.4 million of the company's ordinary shares at a price of AUD $1.07 per ordinary share following a general meeting of its shareholders, who voted overwhelmingly in favor of approving the second tranche of the financing. As a result of receiving shareholder approval, Benitec will receive a total of approximately AUD $31.5 million to accelerate clinical development of its lead compound TT-034, a potential "single shot" treatment for hepatitis C. Proceeds will also be used to advance other programs in the company's pipeline, with a particular emphasis on the lung cancer, age-related macular degeneration, and hepatitis B programs.

Downtrend Call Working As Blount International Stock Falls 10.3% (BLT)
Comtex SmarTrend(R) - Mon Apr 14, 11:22AM CDT
SmarTrend identified a Downtrend for Blount International (NYSE:BLT) on January 27th, 2014 at $12.78. In approximately 3 months, Blount International has returned 10.25% as of today's recent price of $11.47.

Zacks Rank #5 Additions for Tuesday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Tuesday

Blount Provides Estimated Date for Filing of Annual Report on Form 10-K
GlobeNewswire - Mon Apr 07, 6:00PM CDT
Blount International, Inc. (NYSE:BLT) ("Blount" or "Company" today announced that it anticipates filing its Annual Report on Form 10-K for the year ended December 31, 2013 on or before April 30, 2014. On March 17, 2014, which was the initial deadline for filing the Company's Form 10-K, Blount filed a Form 12b-25 which extended the filing date to March 31, 2014.

Zacks Rank #5 Additions for Monday - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 24, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday

Blount International Announces Senior Vice President, Global Sales & Marketing
GlobeNewswire - Thu Mar 20, 3:30PM CDT
Blount International, Inc. (NYSE:BLT) ("Blount" or "Company" announced today that David P. Gillrie, previously President of Blount's Concrete Cutting and Finishing division, has accepted the position of Senior Vice President, Global Sales & Marketing for the Forestry, Lawn, and Garden ("FLAG" division. Mr. Gillrie joined Blount in 2012 after holding positions as a Global General Manager at Terex Corporation and Vice President for Business Development at Ingersoll Rand.

Is Blount International (BLT) Ready to Breakout? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 20, 7:38AM CDT
Is Blount International (BLT) Ready to Breakout?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Greenberg Traurig Builds Real Estate Bench Further

Updated Category News Views 71

Two real estate lawyers rarely move a market, but they can tell you where the legal work is getting sticky. Greenberg Traurig’s November 19 addition of Steven A. Fein and Kelsey Thayer is not some grand macroeconomic pronouncement, and nobody should pretend otherwise. It is, however, a pretty sensible read on the messy corners of commercial property finance: joint...

Continue Reading
Hydron’s Bailey Test Puts RNG Cost Claims to Real Work

Updated Category News Views 55

Landfill gas is messy stuff, which is exactly why Hydron Energy’s Bailey Landfill demonstration in Chilliwack deserves more attention than another clean-energy press release. The British Columbia company is putting its INTRUPTor™ gas-separation system into an operating environment alongside FortisBC and the City of Chilliwack, where the machinery has to deal with real...

Continue Reading
Lecanemab's Alpha-Syn Signal Deserves a Cooler Head

Updated Category News Views 108

Mixed pathology is where Alzheimer's investing gets uncomfortably real, and this new lecanemab readout is a decent reminder that a drug can show promise without settling the argument. Eisai and Biogen presented a Clarity AD cerebrospinal-fluid substudy at CTAD 2026 examining people with early Alzheimer's disease who also tested positive for alpha-synuclein pathology. The...

Continue Reading
Birkenstock’s Athens Stores Put Brand Control to Work

Updated Category News Views 41

A 62-square-meter shop on Ermou Street can say plenty about a brand’s ambitions. Birkenstock is opening its first two Greek stores in Athens, moving beyond its existing wholesale and retail-partner presence with locations it can shape from the floorboards up. The first site at Ermou 18 is stated to have opened on November 12, 2026; the announcement itself is dated...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 163

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
Central Florida Buyers Face the Cash Reality First

Updated Category News Views 44

A house hunt can go sideways before the first showing if the buyer has confused a dream budget with a real one. Tom McKnight’s guidance for first-time buyers in Central Florida lands on the unglamorous stuff, which is exactly where it ought to land: cash, credit, financing, insurance, taxes, and the physical condition of the house. Nobody enjoys staring at lender...

Continue Reading
West Virginia SEO Timelines Demand Patience, Not Hype

Updated Category News Views 54

A fresh website with no search footprint is not a race car; it is a pickup stuck in mud, and Sean O'Kelly's view of local SEO in West Virginia puts that inconvenient fact right on the table. Most businesses can expect measurable improvement after three to six months of consistent work, according to the HelloNation article. That is not a glamorous answer, but it is the...

Continue Reading
Visa CEDP Data Gaps Are Quietly Hammering Merchants

Updated Category News Views 100

Somewhere between a checkout button and settlement, an awful lot of money is apparently falling through a trapdoor. Verisave and Canyon Payments say 93% of the 180 merchant accounts they reviewed during one month missed Visa Commercial Enhanced Data Program discounts they could have received. The claimed savings left on the table topped $800,000 for that group in that...

Continue Reading
RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 30

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
PG&E's $456 Million Interim Hike Faces a New Test Soon

Updated Category News Views 198

A utility can call a charge interim, but households still see the bill arrive in full. That is why the California Public Utilities Commission's unanimous approval of $456 million in interim rate recovery for Pacific Gas & Electric has landed with such rotten timing. The money is set to begin flowing from customers on January 1, 2027, while major questions about PG&E's...

Continue Reading

Top 5 Most Recently Viewed Articles

Insiders Buy Up on MicroStrategy While Analysts Expect Growth

Updated Category News Views 198

Insider Purchases Indicate Confidence in MicroStrategy Recently, insiders at MicroStrategy Incorporated (NASDAQ: MSTR) have made notable stock purchases that are turning heads in the financial community. Even though there were increases in insider share sales in the last quarter, which reached a two-year peak, the market has not reacted unfavorably. Most of these sales...

Continue Reading
Burlington Stores Insider Transaction: Stephen Ferroni's Move

Updated Category News Views 174

Burlington Stores Insider Transaction Details In a significant move recently disclosed in an SEC filing, Stephen Ferroni, the Senior Vice President at Burlington Stores, made headlines by exercising company stock options. This transaction, involving the exercise of options for 1,123 shares, amounted to a transaction value of approximately $200,331. The filing highlights...

Continue Reading
Clairvest Group's Strategic Acquisition of MGM Northfield Park

Updated Category News Views 371

Clairvest Group Expands Horizons with MGM Northfield Park Acquisition Exciting developments are shaping the landscape for Clairvest Group Inc. as they embark on a significant acquisition journey with MGM Northfield Park. This strategic move not only highlights Clairvest's commitment to growth in the gaming sector but also enhances their longstanding reputation for...

Continue Reading
Innovent Biologics Showcases Promising Research at ADA 85th Sessions

Updated Category News Views 576

Innovent Biologics Presents Cutting-Edge Research at ADA Innovent Biologics, Inc. (HKEX: 01801) has made significant advancements in the biopharmaceutical industry, focusing on innovative treatments for oncology, autoimmune diseases, and metabolic conditions. Recently, the company announced that it will showcase exciting results from its research pipeline at the American...

Continue Reading
Promising Results from HERIZON-GEA-01 Trial Support Ziihera®

Updated Category News Views 288

Encouraging HERIZON-GEA-01 Phase 3 Findings Reinforce Ziihera®’s Role Ziihera, when combined with chemotherapy, has demonstrated a significant improvement in progression-free survival (PFS) compared to trastuzumab and chemotherapy combinations. It also showed a strong trend towards enhancing overall survival (OS) at the first analysis. Clinical Outcomes of Ziihera in...

Continue Reading